Hints and tips:
Showing results for Bayer Healthcare Phamaceuticals, Inc.
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
...“[Investors] have been fairly traumatised by the Bayer Monsanto situation and the Johnson & Johnson talc litigation,” said Bernstein analyst Lisa Clive, referring to two recent multibillion-dollar payouts...
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
...Bayer, for instance, has struggled since digesting its Monsanto purchase, with its market value falling by more than $45bn since the deal.....
...His hedge fund Elliott Management has disclosed a stake in the software company SAP, the troubled healthcare and agriculture conglomerate Bayer and the online classifieds group Scout24, this year alone....
...software company valued at $2.5bn, says he has spent a lot of time trying to figure out why Germany has lost the spirit of the Gründerzeit — the “founding epoch” in the late 19th century when Daimler, Bayer...
...It was this statement of corporate social responsibility — crafted decades before the term became overused PR — which he said had guided the world’s largest healthcare company to become a solid, long-term...
...The 62-year old, who’s a supervisory board member at Bayer, witnessed the unprecedented vote of no confidence that investors delivered to the company last month....
...Two years later, the share price of Covestro, the plastics unit of German chemicals company Bayer, doubled within its first year as an independent company, trouncing Bayer’s performance....
...That puts it ahead of its nearest competitors Johnson & Johnson, Sanofi and Bayer, which hold about 4 per cent market shares each....
...Reckitt cited financial discipline for quitting the two-horse race, as it also did in 2014, when it withdrew from bidding for the healthcare unit of Merck of the US, leaving Germany’s Bayer to clinch the...
...In 2014, Bayer paid seven times sales to German peer Merck in a $14bn deal....
...Nestlé, the Swiss foods group, has said that it is in the market for such assets, while analysts also cite drugmakers such as GlaxoSmithKline, Bayer, Sanofi and Johnson & Johnson as potential buyers....
...By acquiring Bayer’s diabetes care business in early 2016 and combining it with the Panasonic division, the new owner was able to double revenues....
...But Alexander Moscho, UK head of Bayer, the German drugmaker, says the qualy system is not flexible enough for the new world of personalised medicines....
...The former Pfizer and Bayer executive has made dealmaking a key pillar of his strategy to strengthen the pharmaceutical company since taking over last year....
...It allows Sanofi to bulk up in consumer healthcare, creating a business with annual revenue of more than €5bn....
...Novartis (animal health and vaccines), Bayer (plastics), Sanofi (animal health) and Pfizer (animal health) have relinquished unwanted businesses or are in the process of doing so....
...Consumer healthcare was among Bayer’s strongest sources of growth after its $14bn acquisition of over-the-counter medicines from Merck of the US last year....
...Jeffrey Holford, analyst at Jefferies, has touted Bayer as another “logical and motivated” potential acquirer....
...“Healthcare has been like a cottage industry but that is beginning to change.”...
...Bayer and Novartis both expressed interest in buying Zoetis before it was carved out of Pfizer, but the rules governing spin-offs made it difficult for them to acquire it during the two years after it became...
...Shire revealed it had approached Baxalta in early July, one day after the Illinois-based company had completed its spin-off from Baxter, the bigger US healthcare group....
...Dr Brandicourt is a Paris-educated medic who rose through the ranks of Pfizer before taking charge of Bayer’s healthcare division in 2013....
...This greater willingness to make clear choices about strategic priorities has been evident in deals such as Bayer’s $14.2bn acquisition of Merck’s consumer healthcare division last year — a transaction that...
International Edition